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Validity of Neutrophil Gelatinase Associated Lipocaline as a Biomarker for Diagnosis of Children with 
Acute Pyelonephritis
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Purpose: Novel biomarkers have been investigated for various renal disorders, including urinary tract infection 
(UTI). The aim of this study was to assess whether urine neutrophil gelatinase associated lipocaline (NGAL), could 
represent a reliable biomarker for diagnosis and treatment of children with acute pyelonephritis (APN).
Materials and Methods: A total of 37 children (32 females, 5 males) with APN were included in this prospective 
study. Urine NGAL was measured before and 5-7 days after antibiotic treatment in the UTI group, using ELISA kit 
and compared with 26 (8 females, 18 males) control group children admitted for other bacterial infections.
Results: Mean age of the UTI group was 39 ± 28 months, compared to 43.6 ± 31.5 months for the control group 
with no statistically significant difference. Median urine NGAL level was significantly higher in patients with APN 
than the other subjects [0.48 (interquartile range (IQR): 0.15-0.72) vs. 0.065 (0.01-0.24), P = .001], and decreased 
significantly after antibiotic treatment (P = .002).
Using a cutoff of 0.20 ng/mL, sensitivity and specificity of urine NGAL were 76% and 77% for prediction of APN, 
respectively. The area under the ROC curve (AUC) for urine NGAL was 0.75 (CI= 0.61-0.88), suggesting urine 
NGAL as a relatively good predictive biomarker of APN. 
Conclusion: Urine NGAL is a good biomarker for diagnosis and treatment monitoring of APN in children.
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INTRODUCTION
Urinary tract infection (UTI) is one of the most com-
mon serious bacterial infections in early life. Early di-
agnosis and treatment of acute pyelonephritis (APN) 
is important to prevent its long-term complications, 
including renal scars, hypertension, and chronic renal 
failure(1) . However, more severe forms of UTI may 
cause dehydration and subsequent prerenal azotemia(2).
Although urine culture has been considered the gold 
standard test for diagnosis of UTI, positive culture 
requires 2–3 days for identification of the respon-
sible organism with false positive and negative re-
sults(3). In addition, sensitivity and specificity of uri-
nary tract symptoms, pyuria, nitrite test, leukocyte 
esterase (LE), WBC, ESR, and CRP are low and 
do not accurately localize upper and lower UTI(4-7). 
DMSA scan have been considered as the gold 
standard test for diagnosis of APN in recent years. 
However, based on new guidelines for the evalua-
tion of APN, DMSA scan has been recommended for 
screening of renal damage 3-6 months following the 
acute phase of infection(8). 
Therefore, it is necessary to develop a sensitive, rap-
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id and noninvasive test with therapeutic implications 
for early diagnosis of APN, especially in suspicious 
patients(9). Neutrophil gelatinase associated lipocalin 
(NGAL) is a recently investigated biomarker for di-
agnosis of acute kidney injury. It is a component of 
the innate immune system(6), which reduces bacterial 
growth in the early phase of inflammation(5), and has 
been identified in different human tissues, including 
renal proximal tubules and neutrophil granules(9,10,11). 
Increased urine NGAL concentration facilitated rapid 
diagnosis of APN in the absence of acute kidney inju-
ry and chronic kidney disease in the recent investiga-
tions (6,9,10). The aim of this study was to determine the 
value of urine NGAL for early prediction of children 
with APN, compared to the other bacterial infections. 
MATERIALS AND METHODS 
This is a hospital based case-control study, conducted 
over a 1-year period between 2014 and 2015. It was
approved by the institutional ethics committee and in-
formed consent was obtained from parents. Inclusion 
criteria consisted of 37 consecutive children less than 
12 years admitted for APN with no other infectious 
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or inflammatory conditions (case group). A to-
tal of 26 age matched children admitted for 
other bacterial infections such as meningitis, pneumo-
nia, septicemia or septic arthritis with no history of 
urological complaints were considered as control group.
APN was defined as positive urine culture (any 
growth in suprapubic aspiration, > 105 CFU/mL of a 
single pathogen in urine bag collection, or > 104 
CFU/mL by uretheral catheterization) associated with 
fever >38.5°C, leukocyte count more than the nor-
mal value according to age, positive CRP, increased 
ESR, and pyuria (urine WBC > 5/hpf). Patients 
with known urologic or anorectal malformations, 
decreased renal function, recent antibiotic treat-
ment, recent history of urological intervention, single 
kidney, associated infections and inflammatory dis-
orders, neurologic disorders, and immunodeficiency 
were excluded from the study. 
Based on new guidelines, DMSA scan was per-
formed in patients with abnormal ultrasound, atypi-
cal UTI, or confirmation of suspicious APN, which 
showed pyelonephritic changes as focal or diffuse 
areas of decreased cortical uptake, with the pres-
ervation of renal contour in 60% of patients(8). 
Urine sample was obtained in both groups before anti-
biotic treatment and 5-7 days after treatment in the UTI 
group, and frozen at –80°C. Urine NGAL was measured 
using a commercially available ELISA kit (BioPor-
to Diagnostics, Gentofte Denmark), according to the 
manufacturer's instructions, and expressed as ng/mL. 
Statistical analysis
Sample size was calculated based on the previous 
study(9) with sensitivity and specificity of 90 and 92%, 
respectively. It was determined by 0.8 estimated power 
and 95% confidence level. Statistical analysis was per-
formed using SPSS software version 22 (Chicago, IL, 
USA). Normality of continuous variables was assessed 
by Kolmogorov-Smirnov test. Normally distributed 
continuous variables were assessed by independent 
sample t-test, whereas Mann-Whitney U test was used 
for group comparison of non- normal continuous vari-
ables. Chi-square test was used to evaluate qualitative 
binary data. Predictive factors of APN were assessed 
by univariate and multivariate analysis on variables 
with P-value ≥ 0.2. Crude and adjusted OR were ob-
tained by stepwise backward logistic regression. Re-
moval probability ˂ 0.1 was considered for stepwise 
analysis. Receiver operating curve (ROC) analysis was 
used to determine optimal cot-off point of sensitivity 
and specificity. Comparison of ROC curve has also 
been performed by STATA SE software version 11. 
    Case  Control  P-value
Subject (%)   37(59)  26(41) 
NGAL ± SD   .47 ± .34  .22 ± .34  0.001a
Age ± SD   39.0 ± 28  43.6 ± 31.5  0.55a
Fever ± SD   38.3 ± .81  38.6 ± 0.36  0.029a
WBC ± SD   13827 ± 5170 12538 ± 4623 0.3b
ESR ± SD   43 ± 22  37 ± 19  0.27 b
Male/Female (%)   5/32(13.5/86.5) 18/8(69/31)  <0.001c
Antibiotic administration (%)  23 (62)  19 (73)  0.366c
   Table 1. Demographic and clinical characteristics of the study groups    
a Mann-Whitney U test, b independent T test, c chi-square test
   Univariable analysis   Multivariable analysis
   OR(CI)  P  Adjusted OR(CI) P
NGAL   8.9(1.67-47.2) 0.01  5.2(0.74-35)  0.09
Age   0.99(.976- 1.01) 0.54  -  -
Fever   0.49(0.21-1.1) 0.085  0.36(0.13-1.006) 0.05
WBC   1  0.3  -  -
ESR   1.01(0.98-1.04) 0.27  -  -
aSex    0.069(0.02-0.24) <0.001  0.079(0.02-0.31) < 0.001
Antibiotic administration 1.6(0.55-4.9)  0.37  -  -
afemale is reference
Table 2. Univariate and multivariable analysis of characteristics associated with the presence of acute pyelonephritis 
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RESULTS
Totally, 37 patients in the APN group and 26 in the 
control group were enrolled in this study. Mean age 
of cases was 39 ± 28 months compared to 43.6 ± 
31.5 months in the control group, with no significant 
difference  (P = 0.55). Female gender was higher in 
APN compared to the control group (86.5% vs. 31%). 
Median urine NGAL level was significantly higher in 
patient with APN than the control group [(0.48 (inter-
quartile range (IQR): 0.15-0.72) vs. 0.065 (0.01-0.24), 
P = .001]. Table 1 demonstrates demographic and lab-
oratory variables in the cases and controls. Mean initial 
urine NGAL was 0.46 ± 0.35 and decreased significant-
ly to 0.25 ± 0.27 after antibiotic treatment (P = .002).
Urine NGAL and gender were associated in univariate 
analysis. However, fever and gender were significant in-
dependent variables in multivariate analysis (Table 2).
The best cutoff level of urine NGAL for predicting APN 
was 0.2 ng/mL. Using these cutoff points, the sensitiv-
ity and specificity of urine NGAL were 74% and 67%, 
respectively (Table 3). The area under the ROC curve 
(AUC) for urine NGAL was 0.75 (CI= 0.61-0.88), sug-
gesting urine NGAL as a relatively good predictive bi-
omarker of APN (Figure 1). There was no significant 
difference in the AUC between reference final model, 
fever (P = .08) and urine NGAL (P = .12) (Table 3). 
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DISCUSSION
This study was performed to evaluate the poten-
tial value of urine NGAL for prediction of children 
with APN. We confirmed significant increase of 
urine NGAL during the acute phase of APN, which 
wasndowngraded with the appropriate treatment. 
The value of serum and urine NGAL for diagno-
sis and therapeutic monitoring of febrile UTI have 
been recently reported. In a similar study, Aram-
basic et al. showed higher level of urine NGAL in 
children with APN compared to acute cystitis and 
other febrile infections. It was considered a use-
ful biomarker for diagnosis of APN in children(12).
In an experimental model of APN, urine NGAL 
increased in the early phase of acute inflamma-
tion following cortical injection of Ecoli, suggest-
ing urine NGAL as a new biomarker of APN(13). 
Urine NGAL was a specific test for evaluation of APN 
in Ghasemi et al. study, compatible with DMSA scan 
grading and CRP level. They recommended measure-
ment of other common biomarkers such as ESR, leu-
kocyte count, and CRP combined with urine NGAL 
for the prediction of renal parenchymal involvement(14). 
In Lee et al. study, urine NGAL was in accord-
ance to the acute photon defects of DMSA renal 
scan, obviating imaging studies in children with 
low urine NGAL level(9). DMSA scan was per-
formed in half of our patients, and nonsignificant 
correlations may not reflect the true incidence. 
However, urine NGAL increased in both up-
per and lower UTI, with no differentiation be-
tween these two groups in the other reports(3).
Similar to our study, urine NGAL significantly de-
creased 3–4 days after antibiotic treatment(7,9) and 
have been considered as predictive biomarker for 
therapeutic monitoring of APN(6). Persistently elevat-
ed urine NGAL may be associated with treatment un-
responsiveness in children with acute febrile UTIs(7). 
We found urine NGAL as a relatively sensitive 
(74%), specific (67%) and accurate test (AUC = 
0.75) for diagnosis of children with APN, which 
was similar to Yim et al. study with 75% sensitivi-
ty and 73.7% specificity(6). However, it was a more 
valid biomarker for diagnosis of UTI with 97% sen-
sitivity and 76% specificity in Yilmaz  et al. report(5). 
Urine NGAL had lower or equal sensitivity and 
specificity for diagnosis of APN, compared to leu-
kocyte esterase; 99% versus 70%, bacteriuria; 81% 
versus 83%(8), urine nitrite; 53% versus 98%, and 
pyuria; 73% versus 81% in our study, respectively.
Increased serum NGAL concentration have been also 
detected as an early biomarker of APN in patients with 
acute bacterial infections(6). Serum NGAL was a rapid 
Table 3. Sensitivity, specificity and area under the curve (AUC) for optimal cut-off values of NGAL, fever and sex compared with full 
model for diagnosis of acute pyelonephritis 
   Sensitivity  Specificity  AUC  Cut off  P-value
Full Model  97.3  69.23  84(0.72-0.95)  -  reference
NGAL   75.68  76.92  75(0.61-0.88)  > = 0.2  0.12
Fever   54.05  88.46  66(0.52-0.79)    0.08
Sex   86.5  69.2  -  -  -
Figure 1. Diagnostic characteristics of NGAL, fever in compari-
son with the full model (NGAL, Fever, and Sex)
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and sensitive test for prediction of APN with a signifi-
cant correlation with DMSA renal cortical defect in the 
acute phase of febrile UTI in Seo et al. study(7), and ex-
cluded radiologic evaluation in lower level. Other studies 
showed a correlation between plasma NGAL level with 
duration of fever, WBC, CRP, and creatinine level(15).
In conclusion, urine NGAL was a relatively sensitive 
and accurate biomarker for differentiation of APN 
from other infectious disorders. However, compared 
to the other parameters, we recommended screening of 
APN with simple inexpensive traditional urinalysis, and 
urine NGAL is suggested to identify highly suspicious 
patients with false negative results, differentiate con-
tamination from urinary tract infection, in addition to 
serve as a therapeutic biomarker. This study provides 
a small piece of evidence that urine NGAL excretion 
could be considered in further and larger populations 
to confirm the potential application of this biomarker.
CONCLUSIONS:
Urine NGAL is a good biomarker for diagno-
sis and treatment monitoring of APN in children.
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